JBT Marel Corporation Common Stock (JBTM)
Fast GrowerFairStock Score: 55/100 — STEADY
Key Financials
| Current Price | $125.41 |
| Market Cap | $6.8B |
| P/E Ratio | 38.59 |
| ROE | 3.92% |
| Dividend Yield | 0.32% |
| Sector | Industrials |
Strengths
- Generates $414 million in annual free cash flow (6.1% yield on market cap)
- Strong Piotroski F-Score of 7/9 indicating robust financial health across profitability, leverage, and efficiency metrics
- Conservative balance sheet with debt-to-equity of just 0.41, providing financial flexibility
- Revenue growth of 115.6% demonstrates strong top-line momentum
- Established organization with 11,500 employees providing operational scale
Concerns
- Trades significantly above Graham Number ($79) with negative 65% margin of safety—limited downside protection
- Altman Z-Score of 1.5 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
JBT Marel Corporation Common Stock is a small-cap industrials company valued at $6.8 billion. The business generates $3.9 billion in annual revenue with a 1.4% net margin and $414 million in free cash flow. From a quality standpoint, JBT shows solid Piotroski F-Score of 7/9 and distressed Altman Z-Score of 1.5 warrants caution. On valuation, the stock is commanding a steep 42.5x multiple, with trades above its Graham Number with a negative 65% margin. Growth dynamics show revenue growing at 115.6% and profit growth of 858.6%. Our composite FairStock Score of 55/100 reflects mixed fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.
Bull Case
JBT's 116% revenue growth trajectory could accelerate as it captures additional market share in the industrials sector. With $414 million in annual free cash flow (6.1% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.
Bear Case
At 42x earnings, any growth disappointment triggers rapid multiple compression—a 20% earnings miss plus multiple contraction to 20x implies 40%+ downside. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer